Tag:

Rotarix

Latest Headlines

Latest Headlines

CDC, FDA studies link Merck and GSK rotavirus vaccines to bowel blockages

Merck's rotavirus vaccine RotaTeq has faced close scrutiny since winning FDA approval in 2006, with authorities monitoring whether it shares side effects with a similar Wyeth product that was pulled from the market. Now a FDA-funded study has shown RotaTeq is linked to the side effect, but the benefits outweigh the risks.

GSK, Merck vaccines keep kids out of hospital

The number of rotavirus-related hospitalizations in kids under 5 fell by 80% after the shots went into routine use, and the hospitalizations in kids 5-14 years dropped by 70%.

Herd immunity from GSK, Merck vaccines cutting hospitalizations

A U.S. Centers for Disease Control and Prevention team has found a significant decrease in the number of rotavirus-related hospitalizations with routine use of GlaxoSmithKline ($GSK) and Merck's ($MRK) rotavirus vaccines in older age groups.

GSK's rotavirus vaccine as effective as Merck shot

The data dampen concerns about Rotarix' efficacy raised in an earlier clinical trial, and shows both vaccines to be effective.

U.K. vaccine expansion a boon for GSK and Merck

Sales of GlaxoSmithKline's rotavirus vaccine Rotarix and Merck's shingles vaccine Zostavax will be buoyed by their inclusion on the U.K. national immunization schedule.

GSK's rotavirus vaccine selected for British program

British health officials selected GlaxoSmithKline's Rotarix vaccine for the country's first routine rotavirus immunization program.

20 Top-selling Vaccines-- H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.

The 20 top-selling vaccines in H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>

Japan ushers in big meds from AZ, GSK, Merck

Japanese health regulators spread some happiness yesterday, granting marketing approval to several major Big Pharma products. AstraZeneca, GlaxoSmithKline, and Merck each got the nod for a key drug

GSK adds bowel risk to Rotarix label

Some evidence has cropped up indicating that GlaxoSmithKline's infant vaccine Rotarix may boost the risk of a rare but potentially fatal bowel problem. It's intussusception--a condition in which the